3D Communications Expands Value Communications for Market Access Services with the Addition of Liz Sherer
Washington, DC—3D Communications LLC today announced the expansion of its global Value Communications for Market Access services adding Liz Scherer, a seasoned communications executive. Liz brings to 3D experience across multiple aspects of the pharma development process – from R&D and Regulatory to Marketing and Commercialization.
“Bringing Liz onto the 3D team enhances our Value Communications for Market Access program across multiple touchpoints,” said Cindy DiBiasi, 3D Communications Co-founder. “Her ability to start with the end goal in mind, coupled with a thorough, cross-functional understanding of how to leverage and optimize content, help clients achieve their market access goals.
As a communications specialist, Liz has a strong reputation for aligning communications across multiple organizational silos and throughout a product’s life cycle. Her work across varied therapeutic areas will also enhance 3D’s signature FDA and EMA Regulatory and Scientific Services. Additionally, Liz’s previous experience leading business development for two digital communications consultancies, and her work as a health reporter will support the messaging and content development work for 3D’s pharmaceutical and health technology clients. Visit Liz’s Blog.
3D Communications has established itself as a global leader in healthcare communications and in helping companies navigate the U.S. regulatory approval process. 3D’s Value Communications for Market Access Services builds upon the company’s more than 15 years of experience in life sciences.
3D Communications is a strategic communications firm that prepares pharmaceutical and device companies for high-stakes regulatory, payer, and other stakeholder interactions. 3D offers a comprehensive and integrated approach to defining, supporting, and articulating value throughout all stages of product development.